Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Snapinn

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
European Heart Journal|December 25, 2004
Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experienceMika Lehto, Steven Snapinn, Kenneth Dickstein, et al.
Clinical Trials (London, England)|July 20, 2018
University of Pennsylvania 10th annual conference on statistical issues in clinical trials: Current issues regarding data and safety monitoring committees in clinical trials (morning panel session)Barry Davis, David Kerr, Maureen Maguire, et al.
European Journal of Heart Failure|August 6, 2005
The impact of morbid events on survival following hospitalization for complicated myocardial infarctionKenneth Dickstein, Gilbert W Gleim, Steven Snapinn, et al.
Circulation|January 29, 2003
Withdrawal of statins in patients with acute coronary syndromesChristopher Heeschen, Christian W Hamm, Ulrich Laufs, et al.
Circulation|March 27, 2002
Withdrawal of statins increases event rates in patients with acute coronary syndromesChristopher Heeschen, Christian W Hamm, Ulrich Laufs, et al.
Headache|December 8, 2019
Content Validity of HIT-6 as a Measure of Headache Impact in People With Migraine: A Narrative ReviewCarrie R Houts, R J Wirth, James S McGinley, et al.
Lancet (London, England)|August 29, 2003
Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE studyLars H Lindholm, Björn Dahlöf, Jonathan M Edelman, et al.
Hypertension (Dallas, Tex. : 1979)|June 3, 2004
Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patientsPeter M Okin, Richard B Devereux, Markku S Nieminen, et al.
Circulation|July 30, 2003
Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) StudyPeter M Okin, Richard B Devereux, Sverker Jern, et al.
The New England Journal of Medicine|December 28, 2022
Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease. ReplyFinnian R Mc Causland, Ajay K Singh, Brian L Claggett, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
European Heart Journal|December 25, 2004
Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experienceMika Lehto, Steven Snapinn, Kenneth Dickstein, et al.
Clinical Trials (London, England)|July 20, 2018
University of Pennsylvania 10th annual conference on statistical issues in clinical trials: Current issues regarding data and safety monitoring committees in clinical trials (morning panel session)Barry Davis, David Kerr, Maureen Maguire, et al.
European Journal of Heart Failure|August 6, 2005
The impact of morbid events on survival following hospitalization for complicated myocardial infarctionKenneth Dickstein, Gilbert W Gleim, Steven Snapinn, et al.
Circulation|January 29, 2003
Withdrawal of statins in patients with acute coronary syndromesChristopher Heeschen, Christian W Hamm, Ulrich Laufs, et al.
Circulation|March 27, 2002
Withdrawal of statins increases event rates in patients with acute coronary syndromesChristopher Heeschen, Christian W Hamm, Ulrich Laufs, et al.
Headache|December 8, 2019
Content Validity of HIT-6 as a Measure of Headache Impact in People With Migraine: A Narrative ReviewCarrie R Houts, R J Wirth, James S McGinley, et al.
Lancet (London, England)|August 29, 2003
Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE studyLars H Lindholm, Björn Dahlöf, Jonathan M Edelman, et al.
Hypertension (Dallas, Tex. : 1979)|June 3, 2004
Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patientsPeter M Okin, Richard B Devereux, Markku S Nieminen, et al.
Circulation|July 30, 2003
Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) StudyPeter M Okin, Richard B Devereux, Sverker Jern, et al.
The New England Journal of Medicine|December 28, 2022
Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease. ReplyFinnian R Mc Causland, Ajay K Singh, Brian L Claggett, et al.
Pageof 4